middle.news
Cynata Wraps Final Patient Visit in Pivotal Osteoarthritis Trial
9:31am on Monday 24th of November, 2025 AEDT
•
Biotechnology
Read Story
Cynata Wraps Final Patient Visit in Pivotal Osteoarthritis Trial
9:31am on Monday 24th of November, 2025 AEDT
Key Points
Final patient follow-up completed in Phase 3 SCUlpTOR trial
Trial evaluates CYP-004’s potential to modify osteoarthritis progression
Data analysis underway with results due in Q2 2026
Osteoarthritis affects 600 million globally with no current cure
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cynata Therapeutics (ASX:CYP)
OPEN ARTICLE